FDA Breakthrough Device Designation
← All partners Partner

Cedars-Sinai Medical Center.

The technology behind LUCY was invented at Cedars-Sinai, validated there, and is licensed exclusively to BlackLight. The hospital is both a clinical partner and a shareholder.

Cedars-Sinai Medical Center

The Cedars-Sinai Medical Center campus at dusk. Dr. Keith Black.
Credible clinical and business partner
  • U.S. News & World Report “Best Hospitals” Honor Roll for the 10th consecutive year; #1 in California.
  • Ranked #9 nationally in total NIH funding among independent hospitals.
  • Exclusively licensed its technologies to BlackLight and actively supports the company as a shareholder.
  • Dr. Keith Black champions the collaboration with BlackLight across numerous Cedars-Sinai disciplines.

Contributions to BlackLight

  1. 1
    Ideation

    Original invention source for BlackLight technologies.

  2. 2
    Validation

    Cedars-Sinai conducted the initial validation studies.

  3. 3
    Publication

    A continuous wave of peer-reviewed papers forthcoming.

  4. 4
    Adoption

    Will lead the roll-out of BlackLight innovations into real-world clinical use.

Cedars Fluorescence Imaging Lab

Three members of the Cedars-Sinai fluorescence imaging team in discussion in the lab.
Reliable R&D collaborator
  • Technology insights: a reliable source of the latest research ideas for BlackLight.
  • Joint R&D: a close collaborator for joint research and development projects.
  • IP ownership: BlackLight funds certain personnel at the Cedars Fluorescence Imaging Lab, and therefore owns the IP arising from such sponsored work.